Research of the Long-COVID-19 Syndrome in the Children
Early Diagnosis, Prognosis and Prevention of Postcovid Syndrome in Children During the Pandemic of the New Coronavirus Infection COVID-19
1 other identifier
interventional
88
1 country
1
Brief Summary
During the pandemic of the new coronavirus infection COVID-19 in the world community, in the Russian Federation, in particular in the Samara region throughout the pandemic period from the end of 2019, when the first outbreak of a new coronavirus infection occurred in Wuhan (Hubei Province) in the People's Republic of China, the main focus on prevention (development of modern vaccines), diagnosis, treatment and further rehabilitation was done on the adult population. Children acted mainly as carriers of this infection and the manifestation of the disease usually occurred in most cases (not counting children with comorbid conditions) in a mild or latent form. At the moment, after 2 years, we can say that postcovid syndrome also occurs in children, regardless of the severity of the disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 9, 2023
CompletedStudy Start
First participant enrolled
April 16, 2023
CompletedFirst Posted
Study publicly available on registry
April 18, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedJanuary 23, 2025
January 1, 2025
1 year
February 9, 2023
January 20, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
postcovid syndrome in children
Number of Participants with research of the bridge syndrome
1 year
Study Arms (1)
Long-COVID-19
EXPERIMENTALconducting laboratory tests, questionnaires, physical examination
Interventions
Eligibility Criteria
You may qualify if:
- children from 6 to 18 years
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Danija
Samara, Pestravka, 446160, Russia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Olga Borisova
Doctor of Sciences, Professor
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 9, 2023
First Posted
April 18, 2023
Study Start
April 16, 2023
Primary Completion
April 30, 2024
Study Completion
December 31, 2024
Last Updated
January 23, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- 2 years
- Access Criteria
- available to everyone
development of a unified integrated model for assessing neurological status, cognitive disorders, somatic disorders of organs and systems to identify patients at risk of chronic infection, prevent the development of such conditions, conduct early personal rehabilitation of children who have undergone COVID-19, and further develop methods for conducting medical examinations